Evidence map›Paper›PMID 40473638›Full record

ArticleNature communications2025

Direct detection of 8-oxo-dG using nanopore sequencing.

Marc Pagès-Gallego, Daan M K van Soest, Nicolle J M Besselink, Roy Straver, Janneke P Keijer, Carlo Vermeulen, Alessio Marcozzi, Markus J van Roosmalen, Ruben van Boxtel, Boudewijn M T Burgering and 2 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Single-Molecule Biodosimetry.Analytical chemistry · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. The Precise Basecalling of Short-Read Nanopore Sequencing.bioRxiv : the preprint server for biology · 2024
    Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Marc Pagès-GallegoCenter for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0001-8888-5699
Daan M K van SoestCenter for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0002-6330-0428
Nicolle J M BesselinkCenter for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0002-8961-4441
Roy StraverCenter for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0002-8031-1735
Janneke P KeijerCenter for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0003-2422-2495
Carlo VermeulenCenter for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.ORCID https://orcid.org/0000-0003-0412-5313
Alessio MarcozziCyclomics, Utrecht, The Netherlands.ORCID https://orcid.org/0000-0001-7477-3661
Markus J van RoosmalenOncode Institute, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0003-3329-1185
Ruben van BoxtelOncode Institute, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0003-1285-2836
Boudewijn M T BurgeringCenter for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. b.m.t.burgering@umcutrecht.nl.ORCID http://orcid.org/0000-0002-4044-9596
Tobias B DansenCenter for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. t.b.dansen@umcutrecht.nl.ORCID http://orcid.org/0000-0001-5259-8815
Jeroen de RidderCenter for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. j.deridder-4@umcutrecht.nl.ORCID http://orcid.org/0000-0002-0828-3477

Funding

KWF Kankerbestrijding (Dutch Cancer Society) 14798KWF Kankerbestrijding (Dutch Cancer Society) Oncode Institute Base Fund
6 · The paper itself

Abstract

Genomic DNA is under constant oxidative damage, with 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxo-dG) being the prominent lesion linked to mutagenesis, epigenetics, and gene regulation. Existing methods to detect 8-oxo-dG rely on indirect approaches, while nanopore sequencing enables direct detection of base modifications. A model for 8-oxo-dG detection is currently missing due to the lack of training data. Here, we develop a strategy using synthetic oligos to generate long, 8-oxo-dG context-variable DNA molecules for deep learning and nanopore sequencing. Our training approach addresses the rarity of 8-oxo-dG relative to guanine, enabling specific detection. Applied to a tissue culture model of oxidative damage, our method reveals uneven genomic 8-oxo-dG distribution, dissimilar context pattern to C>A mutations, and local 5-mC depletion. This dual measurement of 5-mC and 8-oxo-dG at single-molecule resolution uncovers new insights into their interplay. Our approach also provides a general framework for detecting other rare DNA modifications using synthetic DNA and nanopore sequencing.

Indexed as

8-Hydroxy-2'-DeoxyguanosineDeoxyguanosineNanopore SequencingDNADNA DamageGuanineHumansMutationNanoporesOxidative StressSequence Analysis, DNA8-Hydroxy-2'-DeoxyguanosineDeoxyguanosineDNAGuanine

Identifiers

PMID40473638
PMCPMC12141616

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.